Page last updated: 2024-10-28

hydroxychloroquine and Bacterial Meningitides

hydroxychloroquine has been researched along with Bacterial Meningitides in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"The epidemiology of Coxiella burnetii infection in the United States is not well characterized."1.48Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017. ( Allan-Blitz, LT; Klausner, JD; Sakona, A; Wallace, WD, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allan-Blitz, LT1
Sakona, A1
Wallace, WD1
Klausner, JD1

Other Studies

1 other study available for hydroxychloroquine and Bacterial Meningitides

ArticleYear
Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017.
    Emerging infectious diseases, 2018, Volume: 24, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; California; Coxiella burnetii; Doxycycline; End

2018